It’s unclear why we were selected for a social media audit. As a company dedicated to developing life-changing cell and gene therapies for patients with limited treatment options, our work is both time-sensitive and highly specialised. Disruptions to our day-to-day operations, particularly in our laboratories, can directly delay the progress of vital new treatments. We’re […]
Apr 11, 2025
Why were we targeted, and why is this concerning?
It’s unclear why we were selected for a social media audit. As a company dedicated to developing life-changing cell and gene therapies for patients with limited treatment options, our work is both time-sensitive and highly specialised. Disruptions to our day-to-day operations, particularly in our laboratories, can directly delay the progress of vital new treatments.
We’re sharing this to remain transparent with our clients, employees, and partners, and to raise awareness of the broader harm such campaigns can cause, not just to us, but to the patient communities we serve.
We remain focused on our mission, supporting clients and collaborators while upholding the high standards of professionalism, transparency, and integrity that define who we are.
If you have any questions about this matter, please contact us at [email protected]
Latest News
eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer to strengthen global commercial strategy
Lucy Foley appointed to BioPhorum Strategic Advisory Board
Efficiency, Scale and the Role of Cohesive CMC and Manufacturing Planning
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.